Judah Frommer
Stock Analyst at Morgan Stanley
(5)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TRVI Trevi Therapeutics | Initiates Coverage On: Overweight | 18 | 8 | 125% | 1 | Aug 21, 2025 | |
APLS Apellis Pharmaceutic... | Maintains: Equal-Weight | 25 26 | 28.22 | -7.87% | 2 | Jul 2, 2025 | |
BPMC Blueprint Medicines | Maintains: Equal-Weight | 102 129 | 129.46 | -0.36% | 2 | Jun 5, 2025 | |
CLDX Celldex Therapeutics | Maintains: Overweight | 46 43 | 22.6 | 90.27% | 2 | May 9, 2025 | |
ABVX Abivax | Assumes: Equal-Weight | 12 | 79.43 | -84.89% | 1 | Mar 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22 24 | 8.82 | 172.11% | 2 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 31 22 | 32.91 | -33.15% | 3 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 6 | 6.46 | -7.12% | 2 | Jan 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 81 106 | 69.9 | 51.65% | 2 | Nov 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 12.02 | 191.18% | 1 | Oct 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 13 | 2.06 | 531.07% | 1 | Apr 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 3 | 2.49 | 20.48% | 1 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 40 | 2.9 | 1279.31% | 8 | Aug 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 4 | n/a | n/a | 3 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 13 | 1.39 | 835.25% | 5 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | 47.82 | -37.26% | 8 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 23 | 19.3 | 19.17% | 5 | Aug 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 50 | 49.78 | 0.44% | 9 | Jul 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 141 | 18.07 | 680.3% | 13 | Jun 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 156 | 17.16 | 809.09% | 5 | May 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 9 | 4.57 | 96.94% | 5 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 175 138 | n/a | n/a | 6 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 21 22 | 24.47 | -10.09% | 2 | Apr 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 7 | 5.91 | 18.44% | 3 | Mar 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 1 | n/a | n/a | 4 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 11 8 | 6.63 | 20.66% | 5 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 27.4 | 67.88% | 5 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 7 | 2.18 | 221.1% | 6 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 51 55 | 15.75 | 249.21% | 3 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 46 | 134.53 | -65.81% | 1 | Feb 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 4 | n/a | n/a | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 10 | n/a | n/a | 2 | Oct 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 49 | 101.37 | -51.66% | 4 | Nov 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 328 370 | 949.52 | -61.03% | 2 | Oct 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 31 | 77.63 | -60.07% | 6 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 76 | 80.32 | -5.38% | 8 | Sep 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 182 | 111.27 | 63.57% | 6 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 107 | 112.86 | -5.19% | 13 | Aug 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 90 95 | 130.6 | -27.26% | 10 | Jul 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 18 | 19.52 | -7.79% | 1 | Jul 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 93 116 | 144.41 | -19.67% | 12 | Jun 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 38 | 97.27 | -60.93% | 4 | May 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 22 | 144.51 | -84.78% | 1 | May 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 33 35 | 67.97 | -48.51% | 9 | Apr 29, 2020 |